FDA
approval
· 2019-05-28
FDA Approved: RANOLAZINE — Original Application (Ajanta Pharma USA Inc.)
Summary
FDA approved Ajanta Pharma USA Inc.'s original application for ranolazine, enabling a generic version of the anti-anginal medication.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for RANOLAZINE (RANOLAZINE)